/GWLL

GWLL Stock - Goldenwell Biotech, Inc.

Q: What is the analyst price target for GWLL?

Analyst price target information is not currently available for GWLL.

Q: What is GWLL's market cap?

Market capitalization information is not currently available for GWLL.

Consumer Defensive|Packaged Foods|OTC

$3.00+0.00%

+$0.00 (+0.00%) • Dec 19

GoAI Score

Weighted average: Momentum (25%) + Sentiment (35%) + Risk (20%) + Value (20%). ≥70 = BUY, ≤35 = SELL.

HOLD

Medium Confidence

Momentum

Momentum Score

Based on price vs 50-day MA (40%), 200-day MA (40%), and MA crossover (20%). Higher = stronger uptrend.

100

Sentiment

Sentiment Score

Based on analyst price target upside. 50 = neutral, 100 = very bullish (25%+ upside expected).

Risk Score

Based on stock beta (volatility). Higher score = lower risk. Red (<40) = high volatility, Green (>60) = stable.

Price Target

Average analyst price target from the last quarter. Shows expected upside/downside from current price.

+10.0%upside

Target: $3.30

AI Analysis PreviewPremium

Real-time AI-powered market analysis

Precise entry/exit price targets

Risk assessment & position sizing

Unlock GoAI Insights for GWLL

Get institutional-grade AI analysis, real-time signals, and deep market intelligence powered by advanced machine learning.

Buy/Sell Signals

94% win rate on Alpha signals

Deep Analysis

Institutional-grade thesis

Real-Time Alerts

SMS & push notifications

Risk Scoring

Multi-factor analysis

Free 14-day trial • No credit card required

Financial Statements

Revenue & Profitability Trend

FY2020

FY2021

FY2022

FY2023

FY2024

← Swipe to see more →

Revenue

Net Income (Profit)

Net Loss

Key Metrics

Market CapN/A

P/E RatioN/A

Beta5.43

52W High$10.00

52W Low$0.20

Avg VolumeN/A

Income Statement (Fiscal Year)

Metric	FY2024	FY2023	FY2022	FY2021	FY2020
Revenue	$139	$2,340	$47,800	$15,967	N/A
Gross Profit	$64	$1,108	$25,186	$8,388	N/A
Gross Margin	46.0%	47.4%	52.7%	52.5%	N/A
Operating Income	$-123,098	$-116,895	$-985,105	$-118,267	$-6,368
Net Income	$-131,498	$-116,895	$-985,097	$-116,981	$-6,324
Net Margin	-94602.9%	-4995.5%	-2060.9%	-732.6%	N/A
EPS	$-0.00	$-0.00	$-0.01	$-0.00	$-0.00

Company Overview

Goldenwell Biotech, Inc., focuses on nutraceutical and dietary supplements business in the United States. The company is developing five products, including JI MAI—bovine cardiac vascular active peptide; cartilage peptide, a type II collagen peptide; and Double Proline AG 3D active collagen peptide, as well as DNA repair tablets and sugar master tablets. The company was incorporated in 2019 and is based in Twinsburg, Ohio.

Visit Website

Frequently Asked Questions about GWLL

What is GWLL's current stock price?

Goldenwell Biotech, Inc. (GWLL) is currently trading at $3.00 per share. The stock has moved +0.00% today.

What is the analyst price target for GWLL?

No analyst price targets are currently available for this stock.

What sector is Goldenwell Biotech, Inc. in?

Goldenwell Biotech, Inc. operates in the Consumer Defensive sector, specifically within the Packaged Foods industry. The company is traded on the OTC exchange.

What is GWLL's market cap?

Goldenwell Biotech, Inc. has a market capitalization of $0.30 billion, making it a small-cap company.

Does GWLL pay dividends?

No, Goldenwell Biotech, Inc. does not currently pay a dividend to shareholders.